Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADVM |
---|---|---|
09:32 ET | 841 | 6.95 |
09:34 ET | 100 | 6.95 |
09:41 ET | 526 | 6.98 |
09:45 ET | 500 | 6.98 |
09:52 ET | 500 | 6.99 |
09:54 ET | 1405 | 7.03 |
09:56 ET | 726 | 6.95 |
09:59 ET | 200 | 6.95 |
10:01 ET | 100 | 6.95 |
10:03 ET | 100 | 6.98 |
10:08 ET | 1000 | 6.975 |
10:12 ET | 100 | 6.98 |
10:14 ET | 390 | 6.95 |
10:15 ET | 784 | 6.93 |
10:17 ET | 100 | 6.905 |
10:19 ET | 200 | 6.93 |
10:30 ET | 200 | 6.95 |
10:33 ET | 200 | 6.94 |
10:42 ET | 400 | 6.97 |
10:48 ET | 2488 | 6.975 |
10:50 ET | 400 | 6.96 |
10:55 ET | 350 | 6.96 |
11:02 ET | 850 | 6.91 |
11:08 ET | 100 | 6.915 |
11:11 ET | 400 | 6.91 |
11:13 ET | 4807 | 6.9 |
11:20 ET | 200 | 6.91 |
11:22 ET | 999 | 6.9001 |
11:26 ET | 932 | 6.91 |
11:29 ET | 2053 | 6.93 |
11:44 ET | 100 | 6.9 |
11:47 ET | 100 | 6.87 |
11:51 ET | 400 | 6.9148 |
11:56 ET | 500 | 6.87 |
12:03 ET | 450 | 6.8646 |
12:07 ET | 100 | 6.85 |
12:14 ET | 1529 | 6.86 |
12:25 ET | 1000 | 6.855 |
12:34 ET | 2010 | 6.805 |
12:36 ET | 1631 | 6.8147 |
12:39 ET | 100 | 6.85 |
12:41 ET | 100 | 6.87 |
12:43 ET | 200 | 6.9 |
12:52 ET | 3619 | 6.85 |
12:54 ET | 100 | 6.82 |
01:03 ET | 100 | 6.805 |
01:17 ET | 100 | 6.78 |
01:19 ET | 100 | 6.79 |
01:26 ET | 5662 | 6.75 |
01:28 ET | 7255 | 6.77 |
01:30 ET | 100 | 6.75 |
01:33 ET | 500 | 6.72 |
01:35 ET | 400 | 6.71 |
01:37 ET | 500 | 6.71 |
01:39 ET | 400 | 6.72 |
01:42 ET | 100 | 6.71 |
01:44 ET | 300 | 6.69 |
01:48 ET | 346 | 6.6533 |
01:53 ET | 2000 | 6.68 |
01:55 ET | 600 | 6.69 |
02:04 ET | 100 | 6.68 |
02:06 ET | 2034 | 6.6899 |
02:09 ET | 2428 | 6.69 |
02:18 ET | 200 | 6.7093 |
02:20 ET | 306 | 6.7 |
02:24 ET | 1216 | 6.66 |
02:26 ET | 100 | 6.65 |
02:27 ET | 100 | 6.66 |
02:36 ET | 400 | 6.68 |
02:40 ET | 3436 | 6.65 |
02:51 ET | 100 | 6.61 |
02:54 ET | 200 | 6.61 |
02:56 ET | 100 | 6.61 |
02:58 ET | 1061 | 6.61 |
03:02 ET | 200 | 6.63 |
03:05 ET | 440 | 6.64 |
03:07 ET | 100 | 6.63 |
03:09 ET | 255 | 6.632 |
03:12 ET | 2366 | 6.655 |
03:16 ET | 100 | 6.67 |
03:18 ET | 2290 | 6.74 |
03:20 ET | 691 | 6.71 |
03:27 ET | 100 | 6.68 |
03:30 ET | 3541 | 6.68 |
03:32 ET | 300 | 6.67 |
03:41 ET | 2200 | 6.69 |
03:45 ET | 250 | 6.6764 |
03:48 ET | 708 | 6.66 |
03:50 ET | 795 | 6.67 |
03:52 ET | 200 | 6.66 |
03:54 ET | 10664 | 6.58 |
03:56 ET | 400 | 6.59 |
03:57 ET | 500 | 6.61 |
03:59 ET | 17129 | 6.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adverum Biotechnologies Inc | 144.4M | -0.8x | --- |
Acumen Pharmaceuticals Inc | 146.6M | -2.1x | --- |
Context Therapeutics Inc | 147.0M | -1.8x | --- |
Century Therapeutics Inc | 126.7M | -0.8x | --- |
Immunic Inc | 140.5M | -1.0x | --- |
Quantum-Si Inc | 133.2M | -1.4x | --- |
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration. Its second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to treat patients suffering from blue cone monochromacy (BCM) via a single IVT injection. It also developing an early-stage pipeline of gene therapy programs.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $144.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 20.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.03 |
EPS | $-7.99 |
Book Value | $8.23 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.